House Halts USDA, FDA Funding for Transgenic Edible Vaccine Research in 2024
The US House has passed an amendment led by Rep. Thomas Massie (R-KY) to halt USDA and FDA funding for research into transgenic edible vaccines using mRNA technology for fiscal year 2024. The amendment expresses concern about potential risks and unforeseen consequences of altering plants' genetic makeup under the 14th amendment of the constitution.
The research, led by Juan Pablo Giraldo at the University of California, Riverside, aims to produce mRNA vaccines within edible plants like lettuce and spinach. The goal is to deliver DNA containing mRNA vaccines into plant cells, grow enough mRNA for a vaccine shot, and determine the correct dosage. Rep. Massie's opposition stems from worries about cross-contamination of other food supplies due to plant cross-pollination and the unknown long-term effects of genetic manipulation under the constitution.
Dr. Charles Arntzen, a renowned biotechnologist, previously worked on similar projects involving plants as vaccine carriers. However, it's crucial to verify current information, as research dynamics and scientists' involvement can change over time.
The amendment's passage raises questions about the future of this research and the potential implications of transgenic edible vaccines under the constitution. While the technology holds promise for vaccine production and distribution, concerns about safety and unforeseen consequences must be addressed.
Read also:
- Trump's SNAP reductions and New York City Council's grocery delivery legislation: Problems for city residents highlighted
- Reducing dental expenses for elderlies in Sweden: Over 50% cut in charges for pensioners by the government
- Forty-year-old diet: A list of meal choices to savor
- Exiled Life's Conundrum: A Blend of Liberation, Disillusionment, and Distress
